Infectious Diseases (all articles)
China’s COVID vaccines are going global — but questions remain
5 May, 2021 | 08:32h | UTCChina’s COVID vaccines are going global — but questions remain – Nature
What’s the future of vaccines linked to rare clotting disorders? Science breaks down the latest
5 May, 2021 | 08:37h | UTC
Perspective | We may never achieve long-term global herd immunity for COVID. But if we’re all vaccinated, we’ll be safe from the worst
5 May, 2021 | 08:33h | UTCSee also: Reaching ‘Herd Immunity’ Is Unlikely in the U.S., Experts Now Believe – The New York Times (free registration required) AND We May Never Get to Herd Immunity – Think Global Health
ATS Guideline: Nucleic acid–based testing for noninfluenza viral pathogens in adults with suspected community-acquired pneumonia – Testing should be considered only in patients with severe CAP and in immunocompromised patients
5 May, 2021 | 08:28h | UTCNews Release: New clinical practice guideline on community acquired pneumonia – American Thoracic Society
M-A: Prone positioning of nonintubated patients with Covid-19 improve oxygenation variables without any reported serious adverse events – randomized trials with patient-relevant outcomes such as the need for intubation or mortality rates are required
4 May, 2021 | 08:52h | UTCProne Positioning of Nonintubated Patients With Coronavirus Disease 2019—A Systematic Review and Meta-Analysis – Critical Care Medicine (link to abstract – $ for full-text)
Prior SARS-CoV-2 infection boosts response to variants after first vaccine dose
4 May, 2021 | 08:51h | UTCOriginal study: Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose – Science
Commentary on Twitter (thread – click for more)
Just published @ScienceMagazine
"After one dose, individuals with *prior infection* showed enhanced T cell immunity, antibody secreting memory B cell response to spike and neutralizing antibodies effective against B.1.1.7 and B.1.351." 👍https://t.co/7cCVM6iqdP pic.twitter.com/GiC43bjwZZ— Eric Topol (@EricTopol) April 30, 2021
WHO lists Moderna vaccine for emergency use
4 May, 2021 | 08:49h | UTCWHO lists Moderna vaccine for emergency use – World Health Organization
COVID studies note online learning stress, fewer cases in schools with protocols
4 May, 2021 | 08:47h | UTCCOVID studies note online learning stress, fewer cases in schools with protocols – CIDRAP
Study 1: COVID-19 Infections Among Students and Staff in New York City Public Schools – Pediatrics
Study 2: Household COVID-19 risk and in-person schooling – Science
Study 3: Caregiver Perceptions of Children’s Psychological Well-being During the COVID-19 Pandemic – JAMA Network Open AND Editorial: It Is Time to End the Debate Over School Reopening
WHO Inches Closer to Approval of Chinese Sinopharm and Sinovac Vaccines
4 May, 2021 | 08:49h | UTCWHO Inches Closer to Approval of Chinese Sinopharm and Sinovac Vaccines – Health Policy Watch
[Preprint] Preventing disproportionate mortality in ICU overload situations: Empirical evidence from the first COVID-19 wave in Europe – “transferring patients proactively out of developing hotspots to less affected regions, well before high ICU workload situations emerge, will improve patient outcomes”
4 May, 2021 | 08:42h | UTC
Novel coronavirus really is seasonal, study suggests
4 May, 2021 | 08:46h | UTCNovel coronavirus really is seasonal, study suggests – LiveScience
Original study: Climate and the spread of COVID-19 – Scientific Reports
[Preprint] Frequency of neurological manifestations in COVID-19: a systematic review and meta-analysis of 350 studies – up to one-third of COVID-19 patients analyzed in this review, 89% of whom were hospitalized, experienced at least one neurological manifestation
4 May, 2021 | 08:44h | UTCCommentary: Study finds one-third of COVID-19 patients experience neurological symptoms – News Medical
Study: Most patients who develop a non-IgE-mediated hypersensitivity reaction to nafcillin can be safely treated with cefazolin
4 May, 2021 | 08:36h | UTC
Commentary on Twitter
New case series found 90% tolerated switching to cefazolin out of 80 patients who experienced non-IgE hypersensitivity reactions to nafcillin.https://t.co/YbFeWS4n4k
Our previous metas-analysis https://t.co/sJBjrx4a3r found higher odds of these reactions with nafcillin. pic.twitter.com/SIWcSuPcct— Antibiotic Tweets (@khalideljaaly) April 28, 2021
M-A: Tocilizumab reduces the need for mechanical ventilation in COVID-19 patients, but the randomized trials included in the analysis showed it has no significant effect on the risk of mortality or adverse events
3 May, 2021 | 05:44h | UTC
Report: The Epidemics that Didn’t Happen – The lessons that can be learned from epidemics that were contained
3 May, 2021 | 05:41h | UTCThe Epidemics that Didn’t Happen – Prevent Epidemics
Commentaries: ‘The next big one must be prevented’: The lessons the world can learn from epidemics that were contained – STAT AND Former CDC director: We can prevent the next pandemic – CNN AND Learning from the “Near Misses” – Global Health NOW
RECOVERY trial: In hospitalized COVID-19 patients with hypoxia and systemic inflammation (C-reactive protein ≥75 mg/L), tocilizumab improved survival and other clinical outcomes
3 May, 2021 | 05:47h | UTCInvited commentary: Tocilizumab in COVID-19: some clarity amid controversy – The Lancet
Shift work is associated with positive COVID-19 status in hospitalized patients
3 May, 2021 | 05:36h | UTCShift work is associated with positive COVID-19 status in hospitalised patients – Thorax
Commentary: Shift Work Linked to Increased Risk for COVID-19 Illness – HealthDay
[Preprint] Estimating the early impact of immunization against COVID-19 on deaths among older adults in Brazil
3 May, 2021 | 05:38h | UTC
Commentary on Twitter (thread – click for more)
https://twitter.com/hildabast/status/1388290899029938179
Analysis: Why is India having a covid-19 surge?
3 May, 2021 | 05:39h | UTCWhy is India having a covid-19 surge? – The BMJ
See also: India Is Counting Thousands Of Daily COVID Deaths. How Many Is It Missing? – NPR AND Opinion: India’s covid-19 crisis is a dire warning for all countries – The Washington Post AND India’s nightmare: Record high cases, vaccine shortages, hospital fires. – The New York Times AND India coronavirus: New record deaths as virus engulfs India – BBC
M-A: The viral shedding time (VST) determines disease transmission and the duration of infectiousness in SARS-CoV-2 infections – this study found that symptomatic infections, infected adults, persons with chronic diseases, and persons receiving corticosteroid treatment have longer VST
3 May, 2021 | 05:37h | UTC
Case series of 12 patients with cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination – all women younger than 60 years, with symptoms from 6 to 15 days after vaccination
3 May, 2021 | 05:43h | UTCSee also: Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021 – Centers for Disease Control and Prevention AND Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021 – Centers for Disease Control and Prevention
Study: Patients with heart failure have a much higher incidence of pneumonia than matched individuals in the population. The development of pneumonia in these patients is associated with a 3- to 4-fold higher risk of cardiovascular and all-cause death.
3 May, 2021 | 05:18h | UTCCommentaries: Pneumonia in HF Patients Is Common, Lethal, and Preventable – TCTMD AND Outcomes of Pneumonia in Patients With Heart Failure – American College of Cardiology
ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury – antimicrobials, herbal and dietary supplements, and anticancer therapeutics are the most common classes of agents
3 May, 2021 | 05:22h | UTC
M-A: Delayed antibiotic prescribing for respiratory tract infections is a safe and effective strategy for most patients
30 Apr, 2021 | 08:33h | UTCCommentaries: Delayed Antibiotic Prescribing Safe for Respiratory Tract Infection – HealthDay
AHA Statement: Prevention of Viridans Group Streptococcal Infective Endocarditis – Antibiotic prophylaxis for invasive dental procedures is suggested only for high-risk patients with the following conditions: 1) cardiac prosthetic valve; 2) previous infective endocarditis; 3) congenital heart disease; or 4) previous heart transplant
30 Apr, 2021 | 08:35h | UTCNews release: Good dental health may help prevent heart infection from mouth bacteria – American Heart Association
Top Things to Know: Prevention of Viridans Group Streptococcal Infective Endocarditis – American Heart Association
Slide set: Prevention of Viridans Group Streptococcal Infective Endocarditis
Commentaries: Commentary for Prevention of Viridans Group Streptococcal Infective Endocarditis – American Heart Association
Commentary on Twitter (thread – click for more)
In 2007, antibiotic prophylaxis to prevent VGS IE was scaled back.
“There was no convincing evidence that VGS IE frequency, morbidity, or mortality has increased since 2007.”
Thanks Drs. @LBaddour1, Daniel DeSimone and Walter Wilsonhttps://t.co/r9It8c3IwA pic.twitter.com/EO3gcKZAzG
— Mayo Clinic Infectious Diseases (@MayoClinicINFD) April 18, 2021